Bafna Pharmaceuticals Ltd posts net profit of Rs. 6.35 crore in Q1 FY2023-24

Bafna Pharmaceuticals Limited has reported Standalone financial results for the period ended June 30, 2023.

Financial Results (Q1 FY2024) - QoQ Comparison

The company has reported total income of Rs. 43.8162 crores during the period ended June 30, 2023 as compared to Rs. 42.5024 crores during the period ended March 31, 2023.

The company has posted net profit / (loss) of Rs. 6.3511 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs. 5.3718 crores for the period ended March 31, 2023.

The company has reported EPS of Rs. 2.68 for the period ended June 30, 2023 as compared to Rs. 2.27 for the period ended March 31, 2023.

Financials	Q1 FY2024	Q4 FY2023	% Change
Total Income	₹ 43.8162 crs	₹42.5024 crs	3.09%
Net Profit	₹6.3511 crs	₹5.3718 crs	18.23%
EPS	₹2.68	₹2.27	18.06%

Financial Results (Q1 FY2024) - YoY Comparison

The company has reported total income of Rs. 43.8162 crores during the period ended June 30, 2023 as compared to Rs.18.2305 crores during the period ended June 30, 2022.

The company has posted net profit / (loss) of Rs.6.3511 crores for the period ended June 30, 2023 as against net profit / (loss) of Rs.1.3621 crores for the period ended June 30, 2022.

The company has reported EPS of Rs.2.68 for the period ended June 30, 2023 as compared to Rs.0.58 for the period ended June 30, 2022.

Financials	Q1 FY2024	Q1 FY2023	% Change
Total Income	₹ 43.8162 crs	₹18.2305 crs	140.35%
Net Profit	₹6.3511 crs	₹1.3621 crs	366.27%
EPS	₹2.68	₹0.58	362.07%

Shares of Bafna Pharmaceuticals Limited was last trading in BSE at Rs. 91.25 as compared to the previous close of Rs. 89.04. The total number of shares traded during the day was 370 in over 6 trades.

The stock hit an intraday high of Rs. 91.25 and intraday low of 89.00. The net turnover during the day was Rs. 33033.00.

Source : Equity Bulls

Keywords

BafnaPharmaceuticals Q1FY24 ResultUpdate